Celebrex-Derived Drug Targets Common Childhood Bone Tumor
- OPACC
- Jun 25, 2012
- 1 min read
Newswise — Jiayuh Lin, PhD, and colleagues at Nationwide Children’s Hospital have developed a drug to target the most common cancerous bone tumor in children, osteosarcoma, using a version of the FDA-approved drug, Celebrex.
Comments